• 时尚资讯
  • 九块邮
  • 手机版
    • 最新折扣
    • 好券直播
    • 品牌券
    • 20封顶
    • 更多导航
      热门活动热门标签
    积分商城
    • 全部>“patents” 共288个商品
      • 默认
      • 销量
      • 价格
    • 预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      plecanatideTRULANCEDruglitigation

      预订 TRULANCE (plecanatide) Drug Profile, 2025: TRULANCE (plecanatide) drug patents, litigation, PTAB cases, clinical tr

      ¥3,018券后¥3,3180人已购买
      优惠券¥300 领券购买 
    • 预订 XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug

      DrugcenobamateXCOPRI预订

      预订 XCOPRI (cenobamate) Drug Profile, 2025: XCOPRI (cenobamate) drug patents, SPCs, clinical trials, drug prices, drug

      ¥3,015券后¥3,3150人已购买
      优惠券¥300 领券购买 
    • 预订 EXONDYS 51 (eteplirsen) Drug Profile, 2025: EXONDYS 51 (eteplirsen) drug patents, litigation, PTAB cases, clinical

      eteplirsenEXONDYSDruglitigation

      预订 EXONDYS 51 (eteplirsen) Drug Profile, 2025: EXONDYS 51 (eteplirsen) drug patents, litigation, PTAB cases, clinical

      ¥3,006券后¥3,3060人已购买
      优惠券¥300 领券购买 
    • 预订 EPSOLAY (benzoyl peroxide) Drug Profile, 2025: EPSOLAY (benzoyl peroxide) drug patents, SPCs, suppliers, API source

      peroxideEPSOLAYbenzoylDrug

      预订 EPSOLAY (benzoyl peroxide) Drug Profile, 2025: EPSOLAY (benzoyl peroxide) drug patents, SPCs, suppliers, API source

      ¥3,006券后¥3,3060人已购买
      优惠券¥300 领券购买 
    • 预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      sacubitrilvalsartanENTRESTODrug

      预订 ENTRESTO (sacubitril; valsartan) Drug Profile, 2025: ENTRESTO (sacubitril; valsartan) drug patents, litigation, PTA

      ¥3,030券后¥3,3300人已购买
      优惠券¥300 领券购买 
    • 预订 VIZIMPRO (dacomitinib) Drug Profile, 2025: VIZIMPRO (dacomitinib) drug patents, SPCs, clinical trials, suppliers, A

      dacomitinibVIZIMPRODrugsuppliers

      预订 VIZIMPRO (dacomitinib) Drug Profile, 2025: VIZIMPRO (dacomitinib) drug patents, SPCs, clinical trials, suppliers, A

      ¥3,015券后¥3,3150人已购买
      优惠券¥300 领券购买 
    • 预订 TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, li

      Drugdolutegravirlamivudinechallenges

      预订 TRIUMEQ (abacavir sulfate; dolutegravir sodium; lamivudine) Drug Profile, 2025: drug patents, patent challenges, li

      ¥3,038券后¥3,3380人已购买
      优惠券¥300 领券购买 
    • 预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      regorafenibSTIVARGADrugchallenges

      预订 STIVARGA (regorafenib) Drug Profile, 2025: STIVARGA (regorafenib) drug patents, patent challenges, litigation, PTAB

      ¥3,065券后¥3,3650人已购买
      优惠券¥300 领券购买 
    • 预订 EPIDUO (adapalene; benzoyl peroxide) Drug Profile, 2025: EPIDUO (adapalene; benzoyl peroxide) drug patents, patent

      adapaleneperoxidebenzoylEPIDUO

      预订 EPIDUO (adapalene; benzoyl peroxide) Drug Profile, 2025: EPIDUO (adapalene; benzoyl peroxide) drug patents, patent

      ¥3,008券后¥3,3080人已购买
      优惠券¥300 领券购买 
    • 预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      kamedoxomilazilsartanEDARBIDrug

      预订 EDARBI (azilsartan kamedoxomil) Drug Profile, 2025: EDARBI (azilsartan kamedoxomil) drug patents, litigation, SPCs,

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 ARNUITY ELLIPTA (fluticasone furoate) Drug Profile, 2025: ARNUITY ELLIPTA (fluticasone furoate) drug patents, litig

      fluticasoneARNUITYELLIPTAfuroate

      预订 ARNUITY ELLIPTA (fluticasone furoate) Drug Profile, 2025: ARNUITY ELLIPTA (fluticasone furoate) drug patents, litig

      ¥3,010券后¥3,3100人已购买
      优惠券¥300 领券购买 
    • 预订 TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials,

      abaloparatideTYMLOSDruglitigation

      预订 TYMLOS (abaloparatide) Drug Profile, 2025: TYMLOS (abaloparatide) drug patents, litigation, SPCs, clinical trials,

      ¥3,018券后¥3,3180人已购买
      优惠券¥300 领券购买 
    • 预订 Blocking Patents in European Competition Law 在欧洲竞争法中阻止专利: 9789403538143

      竞争法欧洲9789403538143Competition

      预订 Blocking Patents in European Competition Law 在欧洲竞争法中阻止专利: 9789403538143

      ¥2,127券后¥2,4270人已购买
      优惠券¥300 领券购买 
    • 预订 BAFIERTAM (monomethyl fumarate) Drug Profile, 2025: BAFIERTAM (monomethyl fumarate) drug patents, clinical trials,

      monomethylBAFIERTAMfumarateDrug

      预订 BAFIERTAM (monomethyl fumarate) Drug Profile, 2025: BAFIERTAM (monomethyl fumarate) drug patents, clinical trials,

      ¥3,020券后¥3,3200人已购买
      优惠券¥300 领券购买 
    • 预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      hydrochloridesolriamfetolSUNOSIDrug

      预订 SUNOSI (solriamfetol hydrochloride) Drug Profile, 2025: SUNOSI (solriamfetol hydrochloride) drug patents, litigatio

      ¥3,029券后¥3,3290人已购买
      优惠券¥300 领券购买 
    • 预订 AIRSUPRA (albuterol sulfate; budesonide) Drug Profile, 2025: AIRSUPRA (albuterol sulfate; budesonide) drug patents,

      budesonidealbuterolAIRSUPRAsulfate

      预订 AIRSUPRA (albuterol sulfate; budesonide) Drug Profile, 2025: AIRSUPRA (albuterol sulfate; budesonide) drug patents,

      ¥3,001券后¥3,3010人已购买
      优惠券¥300 领券购买 
    • 预订 COSELA (trilaciclib dihydrochloride) Drug Profile, 2025: COSELA (trilaciclib dihydrochloride) drug patents, litigat

      dihydrochloridetrilaciclibCOSELADrug

      预订 COSELA (trilaciclib dihydrochloride) Drug Profile, 2025: COSELA (trilaciclib dihydrochloride) drug patents, litigat

      ¥3,044券后¥3,3440人已购买
      优惠券¥300 领券购买 
    • 预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ubrogepantDrugUBRELVYlitigation

      预订 UBRELVY (ubrogepant) Drug Profile, 2025: UBRELVY (ubrogepant) drug patents, litigation, SPCs, clinical trials, drug

      ¥3,018券后¥3,3180人已购买
      优惠券¥300 领券购买 
    • 预订 International Public Health: Patients’ Rights vs. the Protection of Patents 国际公共卫生:患者权利与专利保护: 9780

      公共卫生InternationalProtection预订

      预订 International Public Health: Patients’ Rights vs. the Protection of Patents 国际公共卫生:患者权利与专利保护: 9780

      ¥1,778券后¥1,9580人已购买
      优惠券¥180 领券购买 
    • 预订 Sub-Patent Innovation Rights: Utility Models, Petty Patents and Innovation Patents Around the World 子专利创新权利

      InnovationPatents预订权利

      预订 Sub-Patent Innovation Rights: Utility Models, Petty Patents and Innovation Patents Around the World 子专利创新权利

      ¥350券后¥4100人已购买
      优惠券¥60 领券购买 
    • 预订 Sub-Patent Innovation Rights: Utility Models, Petty Patents and Innovation Patents Around the World 子专利创新权利

      InnovationPatents预订权利

      预订 Sub-Patent Innovation Rights: Utility Models, Petty Patents and Innovation Patents Around the World 子专利创新权利

      ¥1,207券后¥1,3870人已购买
      优惠券¥180 领券购买 
    • 预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      AURYXIAcitrateferricDrug

      预订 AURYXIA (ferric citrate) Drug Profile, 2025: AURYXIA (ferric citrate) drug patents, litigation, clinical trials, dr

      ¥3,020券后¥3,3200人已购买
      优惠券¥300 领券购买 
    • 预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      dapagliflozinFARXIGADruglitigation

      预订 FARXIGA (dapagliflozin) Drug Profile, 2025: FARXIGA (dapagliflozin) drug patents, litigation, PTAB cases, SPCs, cli

      ¥3,049券后¥3,3490人已购买
      优惠券¥300 领券购买 
    • 预订 ACTOPLUS MET (metformin hydrochloride; pioglitazone hydrochloride) Drug Profile, 2025: Drug patents, patent challen

      hydrochlorideDrugpioglitazonemetformin

      预订 ACTOPLUS MET (metformin hydrochloride; pioglitazone hydrochloride) Drug Profile, 2025: Drug patents, patent challen

      ¥3,004券后¥3,3040人已购买
      优惠券¥300 领券购买 
    • 预订 NEXLETOL (bempedoic acid) Drug Profile, 2025: NEXLETOL (bempedoic acid) drug patents, SPCs, drug prices, drug price

      DrugbempedoicNEXLETOLacid

      预订 NEXLETOL (bempedoic acid) Drug Profile, 2025: NEXLETOL (bempedoic acid) drug patents, SPCs, drug prices, drug price

      ¥3,004券后¥3,3040人已购买
      优惠券¥300 领券购买 
    • 预订 TEPMETKO (tepotinib hydrochloride) Drug Profile, 2025: TEPMETKO (tepotinib hydrochloride) drug patents, SPCs, drug

      hydrochloridetepotinibTEPMETKODrug

      预订 TEPMETKO (tepotinib hydrochloride) Drug Profile, 2025: TEPMETKO (tepotinib hydrochloride) drug patents, SPCs, drug

      ¥3,023券后¥3,3230人已购买
      优惠券¥300 领券购买 
    • 预订 AUSTEDO XR (deutetrabenazine) Drug Profile, 2025: AUSTEDO XR (deutetrabenazine) drug patents, PTAB cases, clinical

      deutetrabenazineAUSTEDODrug预订

      预订 AUSTEDO XR (deutetrabenazine) Drug Profile, 2025: AUSTEDO XR (deutetrabenazine) drug patents, PTAB cases, clinical

      ¥3,010券后¥3,3100人已购买
      优惠券¥300 领券购买 
    • 预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      glycopyrroniumtosylateQBREXZADrug

      预订 QBREXZA (glycopyrronium tosylate) Drug Profile, 2025: QBREXZA (glycopyrronium tosylate) drug patents, litigation, S

      ¥3,005券后¥3,3050人已购买
      优惠券¥300 领券购买 
    • 预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      delafloxacinmeglumineBAXDELADrug

      预订 BAXDELA (delafloxacin meglumine) Drug Profile, 2025: BAXDELA (delafloxacin meglumine) drug patents, litigation, SPC

      ¥3,022券后¥3,3220人已购买
      优惠券¥300 领券购买 
    • 预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      bexagliflozinBRENZAVVYDruglitigation

      预订 BRENZAVVY (bexagliflozin) Drug Profile, 2025: BRENZAVVY (bexagliflozin) drug patents, litigation, suppliers, API so

      ¥3,041券后¥3,3410人已购买
      优惠券¥300 领券购买 
    • 预订 APLENZIN (bupropion hydrobromide) Drug Profile, 2025: APLENZIN (bupropion hydrobromide) drug patents, patent challe

      hydrobromidebupropionAPLENZINDrug

      预订 APLENZIN (bupropion hydrobromide) Drug Profile, 2025: APLENZIN (bupropion hydrobromide) drug patents, patent challe

      ¥3,008券后¥3,3080人已购买
      优惠券¥300 领券购买 
    • 预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      dolutegravirlamivudineDOVATOsodium

      预订 DOVATO (dolutegravir sodium; lamivudine) Drug Profile, 2025: DOVATO (dolutegravir sodium; lamivudine) drug patents,

      ¥3,051券后¥3,3510人已购买
      优惠券¥300 领券购买 
    • 预售 Patented:1000 Design Patents进口艺术 1000项设计专利 Phaidon【中商原版】

      中商1000预售原版

      预售 Patented:1000 Design Patents进口艺术 1000项设计专利 Phaidon【中商原版】

      ¥175券后¥1800人已购买
      优惠券¥5 领券购买 
    • 预订 Reinventing Hoodia: Peoples, Plants, and Patents in South Africa 重塑蝴蝶亚属植物:南非的人民、植物与专利(平装):

      南非植物重塑平装

      预订 Reinventing Hoodia: Peoples, Plants, and Patents in South Africa 重塑蝴蝶亚属植物:南非的人民、植物与专利(平装):

      ¥256券后¥2860人已购买
      优惠券¥30 领券购买 
    • 预售 1000项专利设计 工业设计 英文原版 Patented:1000 Design Patents Phaidon出版社精装艺术书

      项专利英文1000工业设计

      预售 1000项专利设计 工业设计 英文原版 Patented:1000 Design Patents Phaidon出版社精装艺术书

      ¥290券后¥3606人已购买
      优惠券¥70 领券购买 
    • 预订 CRESEMBA (isavuconazonium sulfate) Drug Profile, 2025: CRESEMBA (isavuconazonium sulfate) drug patents, SPCs, clini

      isavuconazoniumCRESEMBAsulfateDrug

      预订 CRESEMBA (isavuconazonium sulfate) Drug Profile, 2025: CRESEMBA (isavuconazonium sulfate) drug patents, SPCs, clini

      ¥3,042券后¥3,3420人已购买
      优惠券¥300 领券购买 
    • 预订 VENCLEXTA (venetoclax) Drug Profile, 2025: VENCLEXTA (venetoclax) drug patents, litigation, PTAB cases, SPCs, clini

      venetoclaxVENCLEXTADruglitigation

      预订 VENCLEXTA (venetoclax) Drug Profile, 2025: VENCLEXTA (venetoclax) drug patents, litigation, PTAB cases, SPCs, clini

      ¥3,126券后¥3,4260人已购买
      优惠券¥300 领券购买 
    • 预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      lefamulinXENLETAacetateDrug

      预订 XENLETA (lefamulin acetate) Drug Profile, 2025: XENLETA (lefamulin acetate) drug patents, litigation, SPCs, clinica

      ¥3,015券后¥3,3150人已购买
      优惠券¥300 领券购买 
    • 预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      larotrectinibVITRAKVIsulfateDrug

      预订 VITRAKVI (larotrectinib sulfate) Drug Profile, 2025: VITRAKVI (larotrectinib sulfate) drug patents, SPCs, clinical

      ¥3,032券后¥3,3320人已购买
      优惠券¥300 领券购买 
    • 预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      eluxadolineVIBERZIDruglitigation

      预订 VIBERZI (eluxadoline) Drug Profile, 2025: VIBERZI (eluxadoline) drug patents, litigation, SPCs, clinical trials, dr

      ¥3,031券后¥3,3310人已购买
      优惠券¥300 领券购买 
    上一页 1 ...  3   4  5  6   7  ... 8 下一页